Your browser doesn't support javascript.
loading
Drug repositioning strategy for the identification of novel telomere-damaging agents: A role for NAMPT inhibitors.
Rizzo, Angela; Maresca, Carmen; D'Angelo, Carmen; Porru, Manuela; Di Vito, Serena; Salvati, Erica; Sacconi, Andrea; Berardinelli, Francesco; Sgura, Antonella; Kuznetsov, Sergey; Potdar, Swapnil; Hassinen, Antti; Stoppacciaro, Antonella; Zizza, Pasquale; Biroccio, Annamaria.
Afiliação
  • Rizzo A; IRCCS-Regina Elena National Cancer Institute, Translational Oncology Research Unit, Rome, Italy.
  • Maresca C; IRCCS-Regina Elena National Cancer Institute, Translational Oncology Research Unit, Rome, Italy.
  • D'Angelo C; IRCCS-Regina Elena National Cancer Institute, Translational Oncology Research Unit, Rome, Italy.
  • Porru M; IRCCS-Regina Elena National Cancer Institute, Translational Oncology Research Unit, Rome, Italy.
  • Di Vito S; IRCCS-Regina Elena National Cancer Institute, Translational Oncology Research Unit, Rome, Italy.
  • Salvati E; Institute of Molecular Biology and Pathology, National Research Council, Rome, Italy.
  • Sacconi A; IRCCS-Regina Elena National Cancer Institute, Clinical Trial Center, Biostatistics and Bioinformatics Unit, Rome, Italy.
  • Berardinelli F; Department of science, "Roma Tre" University, Rome, Italy.
  • Sgura A; Department of science, "Roma Tre" University, Rome, Italy.
  • Kuznetsov S; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Potdar S; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Hassinen A; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Stoppacciaro A; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy.
  • Zizza P; IRCCS-Regina Elena National Cancer Institute, Translational Oncology Research Unit, Rome, Italy.
  • Biroccio A; IRCCS-Regina Elena National Cancer Institute, Translational Oncology Research Unit, Rome, Italy.
Aging Cell ; 22(11): e13944, 2023 11.
Article em En | MEDLINE | ID: mdl-37858982

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Limite: Humans Idioma: En Revista: Aging Cell Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias de Mama Triplo Negativas Limite: Humans Idioma: En Revista: Aging Cell Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália